Physician profile
Michael B Gottsman
NPI 1891718383
$7,289.71
in general payments reported to CMS, 2019-2025
20 companies · $540 in 2025
The $540 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,689 · 2020: $150 · 2021: $1,057 · 2022: $158 · 2023: $471 · 2024: $3,224 · 2025: $540.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Long Term Medical Supply Or Device Loan: $2,459 · Food and Beverage: $1,776.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Long Term Medical Supply Or Device Loan | $2,459.02 |
| Food and Beverage | $1,776.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $2,608.71 | 2019-2024 | Persona, Rosa |
| Medical Device Business Services, INC. | $1,529.28 | 2019-2021 | |
| Depuy Synthes Sales INC. | $1,266.57 | 2019-2024 | Orthovisc |
| Smith+Nephew, INC. | $535.29 | 2019-2025 | Real Intelligence, Journey II, Pico 14 |
| Medacta USA, INC. | $384.19 | 2022-2024 | |
| Microport Orthopedics INC | $186.29 | 2023 | Mpo Medial Pivot Knee |
| Becton, Dickinson and Company | $157.82 | 2024 | Arista Ah Flexitip |
| Heron Therapeutics, INC. | $106.18 | 2025 | Zynrelef |
| Curonix LLC | $90.81 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbott Laboratories | $74.64 | 2021-2025 | Eterna |
| Vertex Pharmaceuticals Incorporated | $65.82 | 2024-2025 | |
| Next Science LLC | $57.13 | 2021 | |
| Cumberland Pharmaceuticals, INC. | $54.22 | 2025 | Caldolor |
| Davol INC. | $41.30 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $30.21 | 2025 | Zilretta, Iovera |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $30.07 | 2024 | Exogen Ultrasound Bone Healing System |
| Boston Scientific Corporation | $25.53 | 2025 | General - Pain Management |
| Fidia Pharma USA INC. | $17.53 | 2025 | Hymovis, Triluron |
| Pacira Therapeutics, INC. | $15.59 | 2019 | |
| Horizon Therapeutics Plc | $12.53 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Gottsman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.